Characteristics | Conservative group (n = 29) | Radical group (n = 30) | P value |
---|---|---|---|
Age at first diagnosis (years) | 33.9 ± 7.4 | 49.3 ± 9.9 | <0.001a |
BMI (Kg/m2) | 22.9 ± 3.7 | 23.6 ± 2.3 | 0.45a |
Nulliparous | Â | Â | <0.001b |
 Yes | 23 | 5 |  |
 No | 6 | 25 |  |
Preoperative serum CA 125 (n = 54) | 50.8 (21.2–327.5) | 140.5 (9.5–2655.0) | 0.026c |
Preoperative serum CA 19–9 (n = 31) | 22.6 (7.5–687.4) | 243.3 (10.1–70,148) | 0.017c |
Tumor size (cm) | 7.5 ± 3.3 | 7.5 ± 3.4 | 0.98a |
Surgical approach | Â | Â | <0.001b |
 Laparoscopy | 21 | 3 |  |
 Laparotomy | 8 | 27 |  |
Complete staging | Â | Â | <0.001b |
 Yes | 9 | 23 |  |
 No | 20 | 7 |  |
Stage | Â | Â | 0.35b |
 I | 28 | 26 |  |
 II-III | 1 | 4 |  |
Microinvasion | Â | Â | 1.00b |
 Yes | 0 | 1 |  |
 No | 29 | 29 |  |
Intra-epithelial carcinoma | Â | Â | 0.14b |
 Yes | 9 | 15 |  |
 No | 20 | 15 |  |
Associated endometriosis | Â | Â | 0.91b |
 Yes | 12 | 15 |  |
 No | 17 | 15 |  |
Endometrial evaluations (n = 47) |  |  | 0.026b |
 Normal | 7 | 18 |  |
 EIN/EC | 11 | 11 |  |
Adjuvant therapy | Â | Â | 0.18b |
 No | 23 | 19 |  |
 Chemotherapy | 6 | 11 |  |